BidaskClub lowered shares of USANA Health Sciences, Inc. (NYSE:USNA) from a sell rating to a strong sell rating in a research report released on Monday, July 31st.
A number of other equities research analysts also recently weighed in on USNA. Zacks Investment Research upgraded USANA Health Sciences from a sell rating to a hold rating in a research report on Wednesday, April 12th. Pivotal Research restated a hold rating and issued a $55.00 target price (down from $75.00) on shares of USANA Health Sciences in a research report on Monday, May 1st.
USANA Health Sciences (USNA) traded up 1.29% during mid-day trading on Monday, reaching $58.80. The company’s stock had a trading volume of 120,279 shares. The firm has a 50-day moving average of $61.54 and a 200-day moving average of $60.59. USANA Health Sciences has a 52 week low of $52.55 and a 52 week high of $150.00. The stock has a market capitalization of $1.47 billion, a price-to-earnings ratio of 15.27 and a beta of 1.10.
USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $1.06 by $0.08. The firm had revenue of $257.10 million during the quarter, compared to analyst estimates of $273.61 million. USANA Health Sciences had a return on equity of 30.12% and a net margin of 9.47%. The business’s revenue for the quarter was down .5% on a year-over-year basis. During the same quarter last year, the company earned $2.07 earnings per share. On average, equities research analysts expect that USANA Health Sciences will post $3.79 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This story was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.com-unik.info/2017/08/11/usana-health-sciences-inc-usna-downgraded-by-bidaskclub-to-strong-sell-updated.html.
USANA Health Sciences declared that its board has initiated a stock buyback plan on Tuesday, July 25th that authorizes the company to repurchase $64.60 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 46% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its shares are undervalued.
In other USANA Health Sciences news, Director Gilbert A. Fuller sold 1,483 shares of the business’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $57.67, for a total transaction of $85,524.61. Following the sale, the director now directly owns 1,483 shares of the company’s stock, valued at approximately $85,524.61. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Myron W. Wentz sold 40,000 shares of the business’s stock in a transaction on Wednesday, August 2nd. The shares were sold at an average price of $56.59, for a total transaction of $2,263,600.00. The disclosure for this sale can be found here. Insiders sold 171,334 shares of company stock worth $10,413,675 in the last ninety days. 53.20% of the stock is owned by corporate insiders.
A number of hedge funds have recently made changes to their positions in USNA. Victory Capital Management Inc. increased its stake in shares of USANA Health Sciences by 124.7% in the first quarter. Victory Capital Management Inc. now owns 2,117 shares of the company’s stock valued at $122,000 after buying an additional 1,175 shares during the period. BNP Paribas Arbitrage SA increased its stake in shares of USANA Health Sciences by 13.1% in the second quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock valued at $135,000 after buying an additional 245 shares during the period. Creative Planning increased its stake in shares of USANA Health Sciences by 528.0% in the second quarter. Creative Planning now owns 2,512 shares of the company’s stock valued at $161,000 after buying an additional 2,112 shares during the period. SG Americas Securities LLC purchased a new stake in shares of USANA Health Sciences during the second quarter valued at about $162,000. Finally, Nine Chapters Capital Management LLC purchased a new stake in shares of USANA Health Sciences during the first quarter valued at about $207,000. 43.90% of the stock is currently owned by institutional investors.
USANA Health Sciences Company Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
What are top analysts saying about USANA Health Sciences Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for USANA Health Sciences Inc. and related companies.